NUS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.457000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.855600E-01
Normal-vs-Stage2
9.531400E-01
Normal-vs-Stage3
2.328200E-01
Normal-vs-Stage4
1.737640E-01
Stage1-vs-Stage2
7.514000E-01
Stage1-vs-Stage3
4.577200E-01
Stage1-vs-Stage4
1.773570E-01
Stage2-vs-Stage3
2.348800E-01
Stage2-vs-Stage4
1.089360E-01
Stage3-vs-Stage4
3.534400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.612200E-01
Normal-vs-AfricanAmerican
4.438200E-01
Normal-vs-Asian
5.798200E-01
Caucasian-vs-AfricanAmerican
1.312430E-01
Caucasian-vs-Asian
2.280200E-01
AfricanAmerican-vs-Asian
9.874400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.526600E-01
Normal-vs-Female
7.980000E-01
Male-vs-Female
2.294200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.692400E-01
Normal-vs-Age(41-60Yrs)
5.683800E-01
Normal-vs-Age(61-80Yrs)
8.940400E-01
Normal-vs-Age(81-100Yrs)
9.573200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.631200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.902800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.678600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.485640E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.449000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.614600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.178000E-01
Normal-vs-Daily Drinker
4.169600E-01
Normal-vs-Weekly Drinker
8.008200E-01
Normal-vs-Occasional Drinker
7.797800E-01
Normal-vs-Social Drinker
8.238800E-01
Non Drinker-vs-Daily Drinker
3.377200E-01
Non Drinker-vs-Weekly Drinker
2.555200E-01
Non Drinker-vs-Occasional Drinker
1.310390E-01
Non Drinker-vs-Social Drinker
1.903840E-01
Daily Drinker-vs-Weekly Drinker
8.091900E-02
Daily Drinker-vs-Occasional Drinker
4.684200E-02
Daily Drinker-vs-Social Drinker
7.898100E-02
Weekly Drinker-vs-Occasional Drinker
9.614800E-01
Weekly Drinker-vs-Social Drinker
9.310400E-01
Occasional Drinker-vs-Social Drinker
9.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.626200E-01
Normal-vs-Grade 2
9.809400E-01
Normal-vs-Grade 3
9.869600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.467200E-01
Grade 1-vs-Grade 3
6.889800E-01
Grade 1-vs-Grade 4
9.626200E-01
Grade 2-vs-Grade 3
8.778600E-01
Grade 2-vs-Grade 4
9.809400E-01
Grade 3-vs-Grade 4
9.869600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.423600E-01
Normal-vs-NonDiabetic
9.013800E-01
Diabetic-vs-NonDiabetic
7.846800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.604000E-01
Normal-vs-NoPancreatitis
9.779200E-01
Pancreatitis-vs-NoPancreatitis
1.091000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.031400E-01
Normal-vs-N1
9.367400E-01
N0-vs-N1
8.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.594600E-01
Normal-vs-TP53-NonMutant
9.572400E-01
TP53-Mutant-vs-TP53-NonMutant
7.273400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
